The researchers analyzed the University Health System Consortium database of adult patients, academic medical centerspic gastric bypass from 2006 to 2009 for the differences in clinical outcomes were based on gender, age and health status before surgery. The majority of the patients in the study were women and within the 31-50 year olds (56, The UHC is an alliance of 107 academic medical centers and 234 of their affiliated hospitals representing approximately 90 % of the national non-profit academic medical centers. scientific basis
The study also showed a trend towards increased risk in older patients, especially those over 50 years old, the oldest group had) . Elderly patients had a significantly higher complication rate 12.82 percent and costs almost $ 4,000 were lying.
AVI BioPharma, Inc. , a developer of RNA-based therapeutic announced that the following inspection by the U.S. Food and Drug administration the company Investigational New Drug application to AVI-4658 be open. AVI-4658 has AVI leading drug candidate as a systemically administration treat of a substantial subset of patients with Duchenne muscular dystrophy , a genetic muscle loss disorder that develop produce the dystrophin causing by non-compliance.S. Launch in this year.